Abbott India Limited header image

Abbott India Limited

500488

Equity

ISIN INE358A01014 / Valor 561999

Bombay Stock Exchange Ltd. (Mumbai) (2026-07-03)

INR 25,850.45+0.50%

Abbott India Limited
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Abbott India Limited is the Indian subsidiary of Abbott Laboratories (NYSE: ABT), a global healthcare company headquartered in the United States. Abbott India is headquartered in Mumbai and manufactures and markets pharmaceutical formulations and consumer healthcare products in India. Key prescription brands include Udiliv (liver disease), Thyronorm (thyroid), Duphalac (laxative), and Creon (digestive enzyme). Key consumer brands include Digene (antacid), Cremaffin (laxative) and Peptazol. The company also has a diagnostics business. Revenue approximately ₹6,100 crore; high dividend payer. Listed on both BSE and NSE (ABBOTINDIA). A Nifty 500 constituent. Market capitalisation approximately ₹35,000–40,000 crore.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-27.1%1Y

11.2%3Y

54.4%5Y

Performance

22.7%1Y

22.4%3Y

23.6%5Y

Volatility

5757 M

Market cap (USD)

1,392

Daily traded volume (Shares)

/

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

0.00

0 votes

Performance:

0.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

EQUITIES OF THE SAME SECTOR

Ultragenyx Pharmaceutical Inc

Ultragenyx Pharmaceutical Inc Valor: 22860122

Annual Return

-50%0%+50%

Risk level

110

3.37%USD 33.47

Pacira BioSciences Inc

Pacira BioSciences Inc Valor: 12338490

Annual Return

-50%0%+50%

Risk level

110

1.44%USD 25.39

Alembic Pharmaceuticals Limited

Alembic Pharmaceuticals Limited Valor: 11500585

Annual Return

-50%0%+50%

Risk level

110

0.91%INR 822.60

Boston Scientific Corp

Boston Scientific Corp Valor: 913577

Annual Return

-50%0%+50%

Risk level

110

4.83%USD 45.14

Cohance Lifesciences Ltd

Cohance Lifesciences Ltd Valor: 46346459

Annual Return

-50%0%+50%

Risk level

110

0.62%INR 454.85

Teladoc Health Inc

Teladoc Health Inc Valor: 28438140

Annual Return

-50%0%+50%

Risk level

110

1.10%USD 9.20

Amphastar Pharmaceuticals Inc

Amphastar Pharmaceuticals Inc Valor: 24511852

Annual Return

-50%0%+50%

Risk level

110

-2.29%USD 19.64

The Platform Group AG

The Platform Group AG Valor: 57796644

Annual Return

-50%0%+50%

Risk level

110

1.69%EUR 0.96

Unitedhealth Group Inc

Unitedhealth Group Inc Valor: 1078451

Annual Return

-50%0%+50%

Risk level

110

-0.28%USD 425.36

Encompass Health Corporation

Encompass Health Corporation Valor: 39085960

Annual Return

-50%0%+50%

Risk level

110

5.00%USD 106.46

SIX

FactSet

Clearbit

Logos provided by Clearbit